Horizon Pharma, Inc. to Present at the 25th Annual ROTH Conference
Published: Mar 11, 2013
DEERFIELD, IL--(Marketwire - March 11, 2013) - Horizon Pharma, Inc. (NASDAQ: HZNP), today announced that Timothy P. Walbert, chairman, president and chief executive officer will present at the 25th Annual ROTH Conference on Monday, March 18th at 8:30a.m. Pacific Time in Laguna Nigel, CA. Mr. Walbert will provide an overview of the Company and its corporate activities.
The presentation will be webcast live and may be accessed by visiting Horizon's website at http://ir.horizon-pharma.com. A replay of the webcast will be available for 10 business days.
About Horizon Pharma
Horizon Pharma, Inc. is a specialty pharmaceutical company that has developed and is commercializing DUEXIS and RAYOS/LODOTRA, both of which target unmet therapeutic needs in arthritis, pain and inflammatory diseases. The Company's strategy is to develop, acquire, in-license and/or co-promote additional innovative medicines where it can execute a targeted commercial approach in specific therapeutic areas while taking advantage of its commercial strengths and the infrastructure the Company has put in place. For more information, please visit www.horizonpharma.com.
Robert J. De Vaere
Executive Vice President and Chief Financial Officer
Burns McClellan, Inc.